Using Sotagliflozin In Tandem with Insulin: Weighing the Benefits in Type 1 Diabetes
Patients with type 1 diabetes often have sub-optimal glycemic control. The gold standard of treatment is basal-bolus insulin or continuous subcutaneous insulin infusion via an insulin pump. However, only a third of patients with type 1 diabetes achieve the American Diabetes Association A1C goal
Create your
podcast in
minutes
It is Free